Pfizer-BioNTech Vaccine Safe, Effective In Young Children Aged 5 To 11 Years, Companies Say

The Washington Post (9/20, Johnson) reports, “A lower dose of the Pfizer-BioNTech coronavirus vaccine – one-third the amount given to adults and teens – is safe and triggered a robust immune response in children as young as 5 years old, the drug companies...